Long-term Follow-up Study of Gaucher Disease

This observational study is looking at the long-term effects of Gaucher disease on different body systems, including the nervous system, liver, and spleen. Researchers also want to understand how well treatments like enzyme replacement therapy (ERT) and substrate reduction therapy (SRT) work over time, and to identify any long-term problems that might come from the disease. You can join this study if you have a diagnosis of Gaucher disease. The study will track these effects over 10 years by reviewing your medical records. The current recruitment status is unclear.

Study design
This is an observational study aiming to enroll 200 participants. It involves reviewing health records over a long period.
What's involved
Your health status will be monitored at least once a year by reviewing your medical records. This study will not change your standard medical care.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 10 years to document the effects of Gaucher disease.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03190837

A Long-term Follow-up Study of Gaucher Disease

Recruiting
Not specifiedAll AgesObservational
Duke University
~200 participants
Updated 2026-09-03 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Document effects of Gaucher disease in different systems of body, including nervous system, liver, and spleen.
Measured over 10 years
Gaucher Disease

NCT03190837

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Duke University Medical Center

    Durham, North Carolinano site contact published

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Priya Kishnani, MD · PRINCIPAL_INVESTIGATOR · Duke University

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of Gaucher Disease
  • Document effects of Gaucher disease in different systems of body, including nervous system, liver, and spleen.10 years

    Use Gaucher patient's natural histories to understand effects of Gaucher Disease long term.